Drug Insights

User-friendly Guide to Find Valsartan on Synapse

29 March 2024
2 min read

Valsartan, a diminutive molecular compound, falls within the pharmacological group of angiotensin receptor blockers (ARBs), which exhibit the ability to selectively obstruct the angiotensin receptor type 1 (AR1R), hence deterring the effects of angiotensin II on the blood vessels, and consequently regulating the blood pressure. It is noteworthy that Valsartan is primarily intended to treat hypertension, heart failure, and myocardial infarction, with its debut approval by the FDA dating back to December 1996, all thanks to the efforts of Novartis in developing it. Valsartan has become widely recognized and hailed as a vital drug in the management of cardiovascular diseases, which serves as a testament to its efficacy and utility. Click on the image below to begin the exploration journey of Valsartan through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Regeneron Announces Progress on Licensing Submission for Cancer Drug Odronextamab
Latest Hotspot
3 min read
Regeneron Announces Progress on Licensing Submission for Cancer Drug Odronextamab
29 March 2024
Regeneron Pharmaceuticals, Inc. has declared the receipt of Complete Response Letters from the U.S. Food and Drug Administration concerning their submitted Biologics License Application for the drug odronextamab.
Read →
What is Preclinical Research?
"What" Series
2 min read
What is Preclinical Research?
29 March 2024
Preclinical research refers to the scientific studies conducted on potential drugs or medical devices before they are tested in humans.
Read →
Rhythm Pharma Begins Human Trials for Weekly MC4R-Targeting Drug RM-718
Latest Hotspot
3 min read
Rhythm Pharma Begins Human Trials for Weekly MC4R-Targeting Drug RM-718
29 March 2024
Rhythm Pharma Initiates First Human Dosing in Early-Stage Study of RM-718, a Once-Weekly Compound Targeting MC4R Receptors.
Read →
Effortless Searching: How to Find Terbinafine on Synapse
Drug Insights
2 min read
Effortless Searching: How to Find Terbinafine on Synapse
29 March 2024
Terbinafine, a small but powerful drug, works by blocking SQLE, a key enzyme in making ergosterol, which is essential for fungal cell membranes.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.